Glutamatergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Glutamatergic neurons are neurons that use glutamate as their primary excitatory neurotransmitter. Glutamate is the most abundant excitatory neurotransmitter in the central nervous system and is essential for synaptic plasticity, learning, memory, and cognitive function. Dysregulation of glutamatergic signaling is implicated in numerous neurodegenerative and neuropsychiatric disorders.
- Layer 2/3: Corticocortical projections
- Layer 5: Subcortical projections, corticospinal tract
- Layer 6: Thalamic projections
- Thalamic relay neurons: Transmit sensory information to cortex
- Granule cells: Cerebellar cortex, olfactory bulb
- Basolateral amygdala: Glutamatergic projection neurons
- Hippocampal CA3 pyramidal cells: Mossy fiber projections
- Cerebral cortex (largest population)
- Hippocampus (CA1, CA3 pyramidal cells)
- Cerebellar cortex (granule cells)
- Thalamus (relay neurons)
- Basolateral amygdala
- Substantia innominata
- VGluT1 (SLC17A7): Vesicular glutamate transporter 1
- VGluT2 (SLC17A6): Vesicular glutamate transporter 2
- VGluT3 (SLC17A8): Vesicular glutamate transporter 3
- EAAC1 (SLC1A1): Excitatory amino acid carrier
- GLUL: Glutamate synthetase (astrocytic)
- Grin1, Grin2A-D: NMDA receptor subunits
- Gria1-4: AMPA receptor subunits
- Grm1-8: Metabotropic glutamate receptor subunits
- Glutamate synthesis: From glutamine via glutaminase
- Vesicular release: Via VGluT transporters
- Reuptake: EAAT1 (GLAST), EAAT2 (GLT-1), EAAT3 (EAAC1)
- Recycling: Astrocyte-neuron glutamate cycle
- GluA1-4 subunits: Fast excitatory transmission
- Calcium permeability: GluA2-lacking receptors
- Conductance: 10-30 pS per channel
- Kinetics: Fast rise (1-2 ms), fast decay (5-10 ms)
- Grin1/Grin2A-D subunits: Voltage-dependent Mg2+ block
- Calcium influx: Critical for synaptic plasticity
- Conductance: 40-50 pS
- Kinetics: Slow rise (5-10 ms), slow decay (100-300 ms)
- Mg2+ block: Relief by depolarization
- GluK1-5 subunits: Mixed excitatory/modulatory
- Conductance: 3-20 pS
- Presynaptic functions: Regulation of release
- Coupling: Gq, phospholipase C
- Postsynaptic: Enhanced excitability, plasticity
- Distribution: Postsynaptic density
- Coupling: Gi/o, adenylyl cyclase inhibition
- Presynaptic: Reduce glutamate release
- Location: Presynaptic terminals
- Coupling: Gi/o
- Presynaptic: Autoreceptor function
- mGluR6: ON-bipolar cells of retina
- Mechanism: Excessive glutamate → overactivation → calcium overload
- Downstream effects: Mitochondrial dysfunction, ROS generation, protease activation
- Target neurons: Vulnerable populations in AD, PD, ALS, stroke
- Early changes: Enhanced glutamate release, impaired reuptake
- Synaptic dysfunction: AMPA/NMDA receptor alterations
- Excitotoxic contributions: Amyloid-beta interactions with glutamate receptors
- Excitotoxicity hypothesis: Corticostriatal glutamate drives excitotoxicity
- mGluR5 antagonists: Neuroprotective in preclinical models
- EAAT2 (GLT-1) loss: Reduced glutamate clearance
- Excitotoxic mechanism: Primary contributor to motor neuron death
- Riluzole: Anti-excitotoxic drug
- mGluR5 antagonists: Fenobam, CTEP
- mGluR2/3 agonists: LY379268
- AMPA receptor modulators: Perampanel
- NMDA receptor antagonists: Memantine (approved for AD)
The study of Glutamatergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- [1] Zhou Y, Danbolt NC. Glutamate transporters in the brain. Handb Exp Pharmacol. 2014.
- [2] Traynelis SF et al. Glutamate receptor ion channels. Pharmacol Rev. 2010.
- [3] Kew JN, Kemp JA. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology. 2005.
- [4] Lewerenz J, Maher P. Glutamate transporters in excitotoxicity and neurological disease. Neurobiol Dis. 2015.
- [5] VanDenBossche J et al. Targeting metabotropic glutamate receptors for the treatment of neurodegenerative disorders. Neuropharmacology. 2017.
- [6] Ossowska K et al. The role of metabotropic glutamate receptors in Parkinson's disease. J Neural Transm. 2017.
- [7] Foran E, Trotti D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal. 2009.
- [8] Hynd MR, Scott HL, Dodd PR. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int. 2004.
- [[mechanisms/glutamatergic-signaling|Glutamate Signaling]]
- [[genes/grin1|GRIN1 Gene]]
- [[genes/grin2a|GRIN2A Gene]]
- [[diseases/als|ALS]]
- [[diseases/alzheimers-disease|Alzheimer's Disease]]